Elevance Health Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | $70.90B | $61.26B | $60.71B |
| Premiums | $85.86B | $83.73B | $79.21B | $73.85B | $68.80B | $65.84B | $56.66B | $56.12B |
| Product Revenues | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Administrative Fees and Other | $6.24B | $6.31B | $5.65B | $5.30B | $5.08B | $5.06B | $4.59B | $4.59B |
| Cost of Revenue | $0 | $0 | — | — | — | — | $137.4M | $0 |
| Gross Profit | $92.11B | $90.04B | — | — | — | — | $61.12B | $60.71B |
| Gross Margin | 100.0% | 100.0% | — | — | — | — | 99.8% | 100.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $14.02B | $12.65B | $12.56B | $12.53B | $11.75B | $9.95B | $8.68B | $8.44B |
| Operating Income | $5.43B | $4.18B | $4.80B | $4.75B | $4.42B | $4.00B | $3.62B | $3.78B |
| Operating Margin | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | 5.6% | 5.9% | 6.2% |
| Interest Expense | $753.0M | $739.0M | $723.0M | $653.0M | $600.7M | $602.7M | $511.8M | $430.3M |
| Pretax Income | $5.07B | $3.96B | $4.56B | $4.63B | $4.37B | $3.84B | $3.86B | $3.96B |
| Income Tax Expense | $1.32B | $121.0M | $2.09B | $2.07B | $1.81B | $1.21B | $1.21B | $1.31B |
| Net Income | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | $2.49B | $2.66B | $2.65B |
| Net Margin | 4.1% | 4.3% | 2.9% | 3.2% | 3.5% | 3.5% | 4.3% | 4.4% |
| EPS (Basic) | $14.53 | $14.70 | $9.39 | $9.73 | $9.31 | $8.34 | $8.26 | $7.35 |
| EPS (Diluted) | $14.19 | $14.35 | $9.21 | $9.38 | $8.99 | $8.20 | $8.18 | $7.25 |
| Shares Outstanding (Basic) | 258.1M | 261.5M | 262.9M | 263.0M | 275.9M | 298.5M | 321.5M | 360.2M |
| Shares Outstanding (Diluted) | 264.2M | 267.8M | 268.1M | 272.9M | 285.9M | 303.8M | 324.8M | 365.1M |
| Dividends Per Share | $3.00 | $2.70 | $2.60 | $2.50 | $1.75 | $1.50 | $1.15 | $1.00 |